VNDA
Vanda Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VNDA fundamentals
Vanda Pharmaceuticals (VNDA) released its earnings on Oct 29, 2025: revenue was 56.26M (YoY +18.07%), missed estimates; EPS was -0.38 (YoY -322.22%), beat estimates.
Revenue / YoY
56.26M
+18.07%
EPS / YoY
-0.38
-322.22%
Report date
Oct 29, 2025
VNDA Earnings Call Summary for Q3,2025
- Revenue Beat: Q3 2025 net product sales $56.3M (+18% YoY), driven by Fanapt (+31%) and HETLIOZ (+35% new prescriptions).
- Pipeline Momentum: 6 potential 2026 launches including tradipitant (FDA Dec 30), Bysanti (FDA Feb 21), and imsidolimab (BLA Q4).
- Commercial Expansion: 300-rep Fanapt sales force achieved 20%+ call volume growth; PONVORY demand up 20% QoQ.
- Financial Focus: 2025 revenue guidance $210-230M, with $293.8M cash as of Q3.
- FDA Collaboration: Positive interactions on tradipitant and HETLIOZ, with priority review for imsidolimab.
EPS
Revenue
Revenue & Expenses
VNDA has released its 2025 Q3 earnings report, with revenue of 56.26M, reflecting a YoY change of 18.06%, and net profit of -22.59M, showing a YoY change of -324.23%. The Sankey diagram below clearly presents VNDA's revenue sources and cost distribution.
Key Indicators
Vanda Pharmaceuticals (VNDA) key financial stats and ratios, covering profitability, financial health, and leverage.
Vanda Pharmaceuticals (VNDA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Vanda Pharmaceuticals (VNDA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Vanda Pharmaceuticals (VNDA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Vanda Pharmaceuticals (VNDA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Vanda Pharmaceuticals (VNDA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Vanda Pharmaceuticals year over year?What were the key takeaways from Vanda Pharmaceuticals’s earnings call?What does Vanda Pharmaceuticals do and what are its main business segments?What is the market's earnings forecast for Vanda Pharmaceuticals next quarter?Did Vanda Pharmaceuticals beat or miss consensus estimates last quarter?What guidance did Vanda Pharmaceuticals's management provide for the next earnings period?What is Vanda Pharmaceuticals's gross profit margin?What is Vanda Pharmaceuticals's latest dividend and current dividend yield?
